BRAF and colorectal carcinoma: Human CRC cells deprived of their mutant KRAS or BRAF oncogenes have lost their transcriptional upregulation of the glucose transporter GLUT1 and the associated ability to grow under low-glucose conditions induced by oncogenic Ras pathway activity [6, 7].